Suppr超能文献

RAMP2 和 RAMP3 在血管系统调节中的功能分化。

Functional differentiation of RAMP2 and RAMP3 in their regulation of the vascular system.

机构信息

Department of Cardiovascular Disease, Shinshu University Graduate School of Medicine, Japan.

Department of Cardiovascular Disease, Shinshu University Graduate School of Medicine, Japan.

出版信息

J Mol Cell Cardiol. 2014 Dec;77:73-85. doi: 10.1016/j.yjmcc.2014.09.017. Epub 2014 Sep 28.

Abstract

Adrenomedullin (AM) is a vasoactive peptide that possesses various bioactivities. AM receptors are dimers consisting of CLR with one of two accessory proteins, RAMP2 or RAMP3. The functional difference between CLR/RAMP2 and CLR/RAMP3 and the relationship between the two receptors remain unclear. To address these issues, we generated RAMP2 and RAMP3 knockout (-/-) mice and have been studying their physiological activities in the vascular system. AM-/- and RAMP2-/- mice die in utero due to blood vessel abnormalities, which is indicative of their essential roles in vascular development. In contrast, RAMP3-/- mice were born normally without any major abnormalities. In adult RAMP3-/- mice, postnatal angiogenesis was normal, but lymphangiography using indocyanine green (ICG) showed delayed drainage of subcutaneous lymphatic vessels. Moreover, chyle transport by intestinal lymphatics was delayed in RAMP3-/- mice, which also showed more severe interstitial edema than wild-type mice in a tail lymphedema model, with characteristic dilatation of lymphatic capillaries and accumulation of inflammatory cells. In scratch-wound assays, migration of isolated RAMP3-/- lymphatic endothelial cells was delayed as compared to wild-type cells, and AM administration failed to enhance the re-endothelialization. The delay in re-endothelialization was due to a primary migration defect rather than a decrease in proliferation. These results suggest that RAMP3 regulates drainage through lymphatic vessels, and that the AM-RAMP3 system could be a novel therapeutic target for controlling postoperative lymphedema.

摘要

肾上腺髓质素(AM)是一种具有多种生物活性的血管活性肽。AM 受体由 CLR 与两种辅助蛋白之一 RAMP2 或 RAMP3 组成的二聚体构成。CLR/RAMP2 和 CLR/RAMP3 之间的功能差异以及这两种受体之间的关系尚不清楚。为了解决这些问题,我们生成了 RAMP2 和 RAMP3 敲除(-/-)小鼠,并一直在研究它们在血管系统中的生理活性。由于血管异常,AM-/-和 RAMP2-/-小鼠在子宫内死亡,这表明它们在血管发育中具有重要作用。相比之下,RAMP3-/-小鼠正常出生,没有任何重大异常。在成年 RAMP3-/-小鼠中,产后血管生成正常,但使用吲哚菁绿(ICG)进行淋巴管造影显示皮下淋巴管引流延迟。此外,RAMP3-/-小鼠的肠道淋巴管乳糜转运延迟,在尾淋巴水肿模型中比野生型小鼠表现出更严重的间质水肿,其特征为淋巴管毛细血管扩张和炎症细胞积聚。在划痕实验中,与野生型细胞相比,分离的 RAMP3-/-淋巴管内皮细胞的迁移延迟,而 AM 给药未能增强再内皮化。再内皮化的延迟是由于原发性迁移缺陷而不是增殖减少。这些结果表明 RAMP3 调节通过淋巴管的引流,并且 AM-RAMP3 系统可能是控制术后淋巴水肿的新的治疗靶点。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验